Endogenous inhibitors of dopamine beta-hydroxylase: separation of multiple forms and access to the enzyme.
D000311:Adrenal Glands / Q000187:drug effects / Q000201:enzymology; D000818:Animals; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006321:Heart / Q000187:drug effects; D006892:Hydroxydopamines / Q000494:pharmacology; D066298:In Vitro Techniques; D007498:Iris / Q000187:drug effects / Q000201:enzymology; D008026:Ligation; D008297:Male; D009206:Myocardium / Q000201:enzymology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012469:Salivary Glands / Q000187:drug effects / Q000201:enzymology / Q000294:innervation; D012584:Sciatic Nerve / Q000502:physiology; D013154:Spleen / Q000187:drug effects / Q000201:enzymology
D006892:Hydroxydopamines; D012110:Reserpine; D004299:Dopamine beta-Hydroxylase